Caerulomycin A is primarily studied for its potential in biomedical applications, particularly due to its antimicrobial and immunosuppressive properties. It has shown activity against certain bacterial strains, making it a candidate for developing new antibiotics. Additionally, its immunosuppressive effects are being explored for use in organ transplantation and autoimmune diseases, where modulating the immune response is crucial. Research is ongoing to understand its mechanism of action and optimize its therapeutic potential.